Wasatch Advisors LP Purchases 39,451 Shares of OrthoPediatrics Corp. $KIDS

Wasatch Advisors LP increased its position in OrthoPediatrics Corp. (NASDAQ:KIDS) by 13.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 329,320 shares of the company’s stock after purchasing an additional 39,451 shares during the quarter. Wasatch Advisors LP owned approximately 1.30% of OrthoPediatrics worth $5,226,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Millennium Management LLC raised its stake in shares of OrthoPediatrics by 48.0% in the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock valued at $24,802,000 after buying an additional 452,840 shares in the last quarter. Vanguard Group Inc. raised its position in OrthoPediatrics by 1.1% in the third quarter. Vanguard Group Inc. now owns 961,330 shares of the company’s stock worth $17,813,000 after purchasing an additional 10,927 shares in the last quarter. Marshall Wace LLP raised its position in OrthoPediatrics by 6.0% in the third quarter. Marshall Wace LLP now owns 444,320 shares of the company’s stock worth $8,233,000 after purchasing an additional 25,191 shares in the last quarter. Prosight Management LP boosted its holdings in OrthoPediatrics by 319.2% during the third quarter. Prosight Management LP now owns 308,707 shares of the company’s stock valued at $5,720,000 after purchasing an additional 235,060 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in shares of OrthoPediatrics by 112.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock valued at $4,937,000 after purchasing an additional 106,041 shares during the period. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Price Performance

OrthoPediatrics stock opened at $20.30 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.37 and a current ratio of 5.21. The firm has a market cap of $521.30 million, a P/E ratio of -12.08 and a beta of 1.03. The business’s fifty day moving average is $17.60 and its two-hundred day moving average is $17.47. OrthoPediatrics Corp. has a 52 week low of $14.42 and a 52 week high of $23.70.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Thursday, April 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.04. The business had revenue of $59.36 million during the quarter, compared to analysts’ expectations of $58.28 million. OrthoPediatrics had a negative return on equity of 7.01% and a negative net margin of 16.31%. Equities research analysts forecast that OrthoPediatrics Corp. will post -1.13 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on KIDS. Wall Street Zen upgraded OrthoPediatrics from a “sell” rating to a “hold” rating in a research report on Saturday, March 7th. Truist Financial set a $17.00 price objective on OrthoPediatrics in a report on Friday, May 1st. Canaccord Genuity Group set a $25.00 target price on shares of OrthoPediatrics in a research note on Friday, April 24th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OrthoPediatrics in a report on Tuesday, April 21st. Finally, BTIG Research reiterated a “buy” rating and set a $24.00 target price on shares of OrthoPediatrics in a research report on Friday, May 1st. Nine investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, OrthoPediatrics presently has an average rating of “Moderate Buy” and a consensus price target of $24.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.